Twist Bioscience Corporation (TWST)
Makes synthetic DNA building blocks for drug discovery, genetic testing, and research labs.
$86.56+0.00%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+157.0%
The outlook
TWST is trading above both its 50- and 200-day moving averages, positioning it in the upper portion of its 52-week range. Analysts lean toward a Buy rating, with an average price target sitting about 7% above the current price. The stock's technical setup and analyst sentiment both tilt constructive relative to recent trading levels.
What’s behind the score
Analyst consensusBuy — 1.5 avg of 10 analysts
Price trendAbove its 50- & 200-day averages
52-week range77% of the way from its 52-week low to high
Price targetAvg target +7% vs current price
Analyst price target
~12-month · 10 analysts$92.50average target+6.9% vs now
Now $86.56
Low $36.00High $120.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$5.39B
52-wk high
$105.47
52-wk low
$23.30
50-day avg
$80.40
200-day avg
$51.43
Trailing P/E
—